Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Emergent BioSolutions Surges
Emergent BioSolutions Inc. (NYSE: EBS) waited until August to announce its first transactions of 2018, but its stock has been rising all year. On August 9, we reported the company acquired specialty vaccine maker PaxVax, Inc. for $270 million. EBS followed that up on August 28 with a $635 million deal for Adapt Pharma, maker of Narcan® (naloxone HCI) Nasal Spray, the only FDA-approved nasal form of naloxone indicated for the emergency treatment of opioid overdose. Upon closing, Emergent will acquire Narcan and a development pipeline of new treatment and delivery options to address opioid overdose. Narcan is expected to generate revenues of $200 million and be accretive to adjusted net... Read More »
Stryker Strengthens Its Spinal Division with K2M Deal
Stryker Corporation (NYSE: SYK) announced its third deal of the year on August 30, acquiring K2M Group Holdings (NASDAQ: KTWO), based in Leesburg, Virginia. Stryker will pay $27.50 per share in an all-cash transaction. The purchase price of approximately $1.4 billion represents a 27% premium over K2M’s average closing price in the 90 trading days ended August 29, 2018. K2M shares rose nearly 26% on news of the deal, opening at around $27.40 per share on August 30, 2018. Stryker’s shares were down nearly 1%, to approximately $170. K2M makes complex and minimally invasive spine “solutions,” which are implants, disposables, and instruments primarily to hospitals for... Read More »
HCA Keeps the Title for Average Price per Hospital Bed
After months of deliberations, for-profit HCA Healthcare (NYSE: HCA) signed a definitive agreement to acquire western North Carolina’s largest health system, not-for-profit Mission Health. The price, approximately $1.5 billion, includes substantially all of Mission Health’s assets. The proceeds of the sale combined with Mission Health’s remaining cash and investments–after all debts and obligations have been paid–will ultimately be transferred to the newly formed Dogwood Health Trust. Under the agreement, HCA will acquire Mission Hospital (763 beds) and CarePartners Rehabilitation Hospital (80 beds), both in Asheville; Mission Hospital McDowell (49 beds) in Marion; Angel... Read More »
Connecticut Cannabis Company Sold to Tuatara Capital
Tuatara Capital didn’t travel far to find its latest investment. While several companies recently have targeted Florida medical cannabis growers (and their licenses), the New York City-based cannabis investor took a drive up I95 to bag Connecticut Pharmaceutical Solutions (CTS). CTS is a licensed medical cannabis cultivator in the state of Connecticut. It manufactures pharmaceutical-grade medical cannabis products, including dried flower, extracted concentrates, vaporizers, tinctures, oral tablets and sprays, and topical treatments. Tuatara Capital is a specialized alternative investment manager founded in 2014 to support the legal cannabis industry. It currently manages more than... Read More »
SOC Telemed Adds Psych Services
SOC Telemed, formerly Specialists On Call, Inc., has added telepsychiatry provider JSA Health to its roster of specialties. SOC Telemed bills itself as the largest national provider of provides video-based specialty physician consultations to acute care hospitals, health systems, post-acute care providers, physician networks, value-based care organizations and health plans. Through its Telemed IQ platform, it provides 24/7 coverage in neurology, psychiatry, critical care and managed services solutions to more than 300 hospitals across 25 states. It’s been in Warburg Pincus’ portfolio since 2014. Houston-based JSA Health provides telepsychiatry services in emergency settings,... Read More »
Brookdale Sells Battery Park Property
Ventas, Inc. (NYSE: VTR) is now in the Long-Term Care record books. On August 20, the REIT announced it will pay $194 million, or $894,000 per unit, for Brookdale Senior Living’s (NYSE: BKD) Brookdale Battery Park property. We think that’s a record per-unit price. It was opened in 2000 at an approximate cost of $50 million. This 14-story, 240,000 square-foot independent living community overlooks the Hudson River in the Battery Park City neighborhood of Manhattan. Occupancy was in the low 90s. The acquisition was valued below replacement cost and represents an approximately 5% going-in yield on net operating income as reported by Ventas. Brookdale will stay on as operator under... Read More »
Tenet Healthcare Rethinks Aspen Deal
Tenet Healthcare Corporation (NYSE: THC) is selling UK-based Aspen Healthcare Ltd. after only three years of ownership. NCM Healthcare UK Ltd., a subsidiary of NCM Health plc (LSE: NCM), is the buyer, paying $332 million. Tenet acquired the nine-facility company from Welsh, Carson, Anderson & Stowe (WCAS) in March 2015, for $215 million. The transaction was announced simultaneously with Tenet’s acquisition of a 5o.1% stake in United Surgical Partners International, another WCAS portfolio company, for $425 million. WCAS, together with other investors, retained a 49.9% interest in USPI at the time of the announcement. On April 26, 2018, Tenet announced that it acquired... Read More »
Health Care M&A Deals, Week Ending August 24, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price bluebird bio, Inc. Collaboration on cancer cell therapy $30 million Sierra Oncology, Inc. Momelotinib $3 million Global Blood Therapeutics, Inc. Worldwide license for inclacumab N/A Harbour BioMed Exclusive license agreement N/A AbbVie Inc. License to... Read More »
Health Care M&A Deals, Week Ending August 17, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Pfizer Inc. Collaboration on mRNA-based vaccines $120 million Portage Biotech Inc. SalvaRx Limited $71.7 million Mustang Bio, Inc. License to X-SCID gene therapy N/A Viscogliosi Brothers, LLC OP-1 product line N/A Bayer AG Development collaboration with... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
